Contact activation of the plasma coagulation cascade. III. Biophysical aspects of thrombin-binding anticoagulants

Journal of Biomedical Materials Research

Volumn 40, Issue 1, 1998, Pages 92-103

  Vogler, Erwin A ^a   Nadeau, James G ^a   Graper, J C ^a  

^a BD Technologies   (United States)

Author keywords

Anticoagulation; Aptamers; Blood; Coagulation; DNA ligands; Mathematical model; Plasma; Thrombin; Thrombin ligand

Indexed keywords

BLOOD; COAGULATION; DISSOCIATION; DNA; LEAST SQUARES APPROXIMATIONS; MATHEMATICAL MODELS; POLYMERIZATION; PROTEINS; REACTION KINETICS;

APTAMERS; FIBRIN; LIGANDS; PLASMA COAGULATION; THROMBIN;

BIOMATERIALS;

ANTICOAGULANT AGENT; FIBRINOGEN; THROMBIN;

ANTICOAGULATION; ARTICLE; DISSOCIATION CONSTANT; MODEL; NONHUMAN; PLASMA; SWINE;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CATTLE; FIBRINOGEN; MODELS, BIOLOGICAL; OLIGODEOXYRIBONUCLEOTIDES; SWINE; THROMBIN;

EID: 0032053413     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199804)40:1<92::AID-JBM11>3.0.CO;2-M     Document Type: Article

References (30)

1. Theta Corporation, Dynamic Medical Disposable Markets in the U.S., 1995, Table 38.
2. E. A. Vogler, J. C. Graper, G. R. Harper, L. M. Lander, and W. J. Brittain, "Contact activation of the plasma coagulation cascade. I. Procoagulant surface energy and chemistry," J. Biomed. Mater. Res., 29, 1005-1016 (1995).
3. L. A. Harker, "Antithrombotic therapy," in Hematology W. J. Williams, E. Bestler, A. J. Ersler, and M. A. Lichtman (eds.), McGraw-Hill, Inc., New York, 1990, pp. 1569-1581.
4. J. Fareed, D. Hoppensteadt, J. M. Walenga, and R. Pifarre, "An overview of current anticoagulant and antithrombotic drugs," in Anticoagulation, Hemostasis, and Blood Preservation in Cardiovascular Surgery, R. Pifarre (ed.), Hanley and Belfus, Philadelphia, 1993, pp. 111-128.
5. X. Ma, S. F. Mohammad, and S. W. Kim, "Interaction of heparin with pollalyamine-immobilized surfaces," J. Biomed. Mater. Res., 27, 357-365 (1993).
6. M. Holodniy, S. Kim, D. Katzenstein, M. Konrad, E. Groves, and T. C. Merigan, "Inhibition of human immunodeficiency virus gene amplification by heparin," J. Clin. Microbiol, 29, 676-679 (1991).
7. S. R. Stone and J. M. Maraganore, "Hirudin and hirudin-based peprides," Meth. Enzymol., Part B, 223, 312-336 (1993).
8. C. Tapparelli, R. Metternich, C. Ehrhardt, and N. S. Cook, "Synthetic low-molecular weight thrombin inhibitors - Molecular design and pharmacological profile," Trends in Pharmacol. Sci, 14, 366-376 (1993).
9. L. C. Bock, L. C. Griffin, J. A. Latham, W. H. Vermass, and J. Toole, "Selection of single-stranded DNA molecules that bind and inhibit human thrombin," Nature, 355, 564-566 (1992).
10. A. DeAnda, S. E. Coutre, M. R. Moon, C. M. Vial, L. C. Griffin, V. S. Law, M. Komeda, L. L. K. Leung, and D. C. Miller, "Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass," Ann. Thorac. Surg., 58, 344-350 (1994).
11. J. G. Nadeau, E. A. Vogler, M. L. Ciolkowski, H. V. Hsieh, K. Harris, and M. J. Mitchell, "Bi-directional oligonucleotides that bind thrombin," Biochemistry, to appear.
12. E. Nakanishi, H. Sato, and A. Nakajima, "Kinetic study on the effects of acidic polysaccharides on the interaction of fibrinogen and thrombin," Polym. Bull, 3, 655-664 (1980).
13. H. Sato and A. Nakajima, "Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin III. Effects of competitive inhibitors," Thromb. Res., 37, 327-335 (1985).
14. H. Sato and A. Nakima, "Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin (I): Application of mathematical treatment of turbidimetrical method," Thromb. Res., 33, 645-651 (1984).
15. H. Sato and A. Nakima, "Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin (II): Application of enzyme kinetics to turbidimetrical method," Thromb. Res., 35, 133-139 (1984).
16. S. D. Lewis, P. P. Shields, and J. A. Shafer, "Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin," J. Biol. Chem., 260, 10192-10199 (1985).
17. P. Wiltzius, G. Dietler, W. Kanzig, V. Hoffman, A. Haberli, and P. W. Straub, "Fibrin aggregation before sol-gel transition," Biophys. J., 38, 123-132 (1982).
18. N. Alkjaersig and A. P. Fletcher, "Formation of soluble fibrin oligomers in purified systems and in plasma," Biochem. J., 213, 75-83 (1983).
19. M. C. Naski and J. A. Shafer, "A kinetic model for the thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin," J. Biol. Chem., 266, 1303-1310 (1991).
20. D. R. Hoak, S. K. Banerjee, and G. Kaldor, "An automated approach to characterize in simple kinetic terms the generation and inactivation of thrombin and the interaction of fibrinogen with thrombin,Clin. Chem., 34, 1971-1975 (1988).
21. D. L. Higgins, S. D. Lewis, and J. A. Shafer, "Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin," J. Biol. Chem., 258, 9276-9282 (1983).
22. E. A. Vogler, "Interfacial chemistry in biomaterials science," in Wettability (Surfactant Science Series 49), J. Berg (ed.), Marcel Dekker, Inc., New York, 1993, pp. 184-250.
23. J. Odink, J. F. M. Smeets, I. J. R. Visser, H. Sandman, and J. M. A. Snijders, "Hematological and clinicochemical profiles of healthy swine and swine with inflammatory processes," J. Animal Sci., 68, 163-170 (1990).
24. M. Picozzi and R. De Cristofaro, "Effect of temperature on the association step in thrombin-fibrinogen interaction," Biochem. J., 294, 563-567 (1993).
25. P. Zoldhelyi, J. H. Cheesbro, and G. O. Whyte, "Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig," Proc. Natl. Acad. Sci. USA, 90, 1819-1823 (1993).
26. D. Beverly, M. Inwood, G. Chance, M. Schaus, and B. O'Keefe, "Normal haemostasis parameters: A study in a well-defined inborn population of preterm infants," Early Human Dev., 9, 249-257 (1984).
27. J. A. Shafer and D. L. Higgins, "Human fibrinogen," CRC Crit. Rev. Clin. Lab. Sci., 26, 1-41 (1988).
28. F. Marongiu, A. M. Mamusa, P. Dessalvi, G. Mameli, A. B. Cambuli, G. G. Sorano, M. Conti, P. Farci, and A. Balestrieri, "Evidence for a relationship between high fibrinogen levels and decreased thrombin activity in vivo in elderly subjects," Haemostasis, 19, 91-93 (1989).
29. Y. M. Le Gal, "Characterization and Quantitation of the five major plasma protein fractions in seven-day-old piglets," Biol. Neonate, 26, 174-181 (1975).
30. I. H. Segel, Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, Wiley, New York, 1975, p. 957.